High prevalence of factor V Leiden mutation in mothers of premature neonates

Biol Neonate. 2000;78(2):145-6. doi: 10.1159/000014263.

Abstract

The prevalence of the Leiden mutation was tested in 50 mothers of premature infants and in 56 mothers of intrauterine-growth-retarded neonates. The prevalence of the Leiden mutation was 7.2% in the mothers of growth-retarded neonates and 18% in the group of mothers of premature infants, the latter being significantly higher than the 6.3% prevalence of this mutation in healthy Hungarian subjects (p < 0.01). In spite of the relatively small number of mothers examined, the unexpected finding may call attention to a hitherto unknown relationship.

MeSH terms

  • DNA Mutational Analysis
  • Deoxyribonucleases, Type II Site-Specific / metabolism
  • Factor V / genetics*
  • Female
  • Fetal Growth Retardation / genetics
  • Humans
  • Hungary
  • Infant, Newborn
  • Infant, Premature*
  • Mutation
  • Polymerase Chain Reaction
  • Pregnancy

Substances

  • factor V Leiden
  • Factor V
  • endodeoxyribonuclease MnlI
  • Deoxyribonucleases, Type II Site-Specific